imatinib mesylate has been researched along with Spondylitis, Ankylosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghaffarpasand, F; Heiran, HR; Khojasteh, HN; Nazarinia, MA; Seraj, SR | 1 |
| Belhadj, S; Ben Abdelghani, K; Chekili, S; El Menaa, M; Laatar, A; Souabni, L; Zakraoui, L | 1 |
2 other study(ies) available for imatinib mesylate and Spondylitis, Ankylosing
| Article | Year |
|---|---|
Imatinib treatment of ankylosing spondylitis in a patient resistant to NSAIDs and infliximab.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Benzamides; Drug Resistance; Humans; Imatinib Mesylate; Infliximab; Male; Piperazines; Pyrimidines; Radiography; Spondylitis, Ankylosing | 2010 |
Chronic myeloid leukemia and ankylosing spondylitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Benzamides; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Spondylitis, Ankylosing | 2012 |